Rights and permissions
About this article
Cite this article
Interferon-β-1b in multiple sclerosis - too costly?. Pharmacoecon. Outcomes News 105, 5 (1997). https://doi.org/10.1007/BF03271437
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03271437